Boston Children's Hospital

What Boston Children's Hospital does

Boston Children's Hospital, founded in 1869 and headquartered at 300 Longwood Avenue in Boston, Massachusetts, is a private non-profit pediatric academic medical center affiliated with Harvard Medical School. It operates more than 300 specialized clinical programs across neonatology, nephrology, urology, cardiology, neurology, oncology, orthopedics, and rare disease diagnosis, supported by over 10,000 employees including more than 3,000 award-winning researchers and staff. Care delivery is organized around a main Longwood Avenue campus, eight satellite outpatient locations across Massachusetts, a community health center (Martha Eliot), an international patient program, an online second opinion service, and the MyChildren's Patient Portal.

Revenue is generated primarily through patient care services billed to commercial insurers, government payers (Medicare/Medicaid/MassHealth), and self-pay patients under published standard charge and negotiated rate schedules, supplemented by substantial philanthropic income including a record $100M gift from the Hale family in December 2025. The hospital's technology stack is anchored by a proprietary clinical intelligence platform, AI-powered clinical diagnostics built on OpenAI's ChatGPT and o3 Deep Research models, the 3DModeler AI orthopedic surgical planning tool, base editing gene therapy platforms, and a world-record fastest human whole genome sequencing workflow developed with Broad Clinical Labs and Roche.

The hospital maintains active research collaborations with Harvard, the Broad Institute, Dana-Farber Cancer Institute, Nippon Shinyaku (neurology drug co-development), and OpenAI (rare disease AI, $50M commitment). It is currently constructing the $640M Hale Family Building, a 116-bed pediatric behavioral health facility on the Brighton campus (Franciscan Children's site) scheduled to open in 2029, and is recognized as the #1 pediatric hospital nationally by U.S. News & World Report in Neonatology, Nephrology, and Urology, and among the world's best by Newsweek.

Name

Boston Children's Hospital

Legal name

The Children’s Hospital Corporation

Website

https://childrenshospital.org

Company type

Private

Founded year

1869

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Boston Children's Hospital is a Harvard-affiliated, non-profit pediatric academic medical center founded in 1869 that delivers more than 300 specialized clinical programs across its Boston campus, eight Massachusetts satellite locations, and an international patient program. It serves children with complex, rare, and behavioral health conditions and is the #1 U.S. pediatric hospital in Neonatology, Nephrology, and Urology.

Ownership category

akta.pro rank

Headquarters

HQ city

Boston

HQ country

United States

HQ region

North America

Offices12 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Patient Care Services: Boston Children's Hospital generates revenue primarily through patient care services including inpatient admissions, outpatient visits, surgical procedures, diagnostic testing, and specialized treatments across its 300+ programs and services.
2. Insurance and Payer Contracts: Hospital charges billed to commercial insurers, government payers (Medicare, Medicaid/MassHealth), and self-pay patients. Standard charges, payer-specific negotiated rates, and discounted cash prices are published for transparency.
3. Philanthropy and Donations: Significant philanthropic revenue including the $100 million Hale Family gift, annual fundraising events (Eversource Walk, Granite 'Saving by Shaving' raising $4.155 million), and donor contributions supporting hospital programs and facilities.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels8 records

Core offering

Boston Children's Hospital is a non-profit pediatric academic medical center that delivers inpatient, outpatient, surgical, diagnostic, and emergency care to infants, children, and adolescents through 300+ specialized clinical programs across its main Longwood campus and satellite locations. The hospital also conducts pediatric clinical research, offers AI-enabled rare disease diagnostics, gene therapies, and orthopedic surgical planning technology, and provides international patient services and online second opinions for families worldwide.

Product overview

Boston Children's Hospital operates as a pediatric healthcare provider with an extensive digital health infrastructure. The hospital offers over 300 specialized programs and services, with key digital products including AI-enabled clinical diagnostics using OpenAI technology for rare disease identification, an internal clinical intelligence platform for patient trajectory monitoring, and 3DModeler for orthopedic imaging. Patient-facing digital services include the MyChildren's Patient Portal and Online Second Opinions program. The hospital's technology strategy emphasizes AI integration for diagnostic capacity expansion and operational efficiency, with reported savings of 60,000+ hours and $7+ million through AI-enabled workflows.

Differentiator

Problem solved

Functional benefit

Brands

• Manton Center for Orphan Disease Research: Research center dedicated to orphan and rare disease research
• MyChildren's Patient Portal
• Fenwick Institute
• Hale Family Center for Families

Products and services

• MyChildren's Patient Portal Patient-facing digital portal (MyChart-based) that allows pediatric patients and families to access medical records, schedule appointments, pay bills, and communicate with care teams.
• Online Second Opinions Virtual second opinion service that allows patients and families worldwide to receive expert evaluations from Boston Children's specialists without traveling to the hospital.
• International Patient Program Dedicated international patient services coordinating complex pediatric care for families traveling from outside the United States to Boston Children's Hospital.
• Pediatric Specialty Care Programs (300+) Comprehensive inpatient, outpatient, surgical, diagnostic, and emergency pediatric care spanning neonatology, nephrology, urology, cardiology, neurology, oncology, orthopedics, and rare disease diagnosis and treatment.
• 3DModeler AI Software AI-powered software that generates 3D bone and tissue models from MRI or CT scans within five minutes, supporting orthopedic surgical planning as an extension of the VirtualHip program.
• Base Editing Gene Therapy for Sickle Cell Disease First-of-its-kind base editing gene therapy for sickle cell disease, involving collection and editing of blood stem cells to produce fetal hemoglobin as a curative treatment.
• AI-Enabled Clinical Diagnostics AI-powered diagnostic system using OpenAI's ChatGPT and o3 Deep Research model to analyze rare disease cases, identify previously undiagnosed conditions, and support clinical decision-making for pediatric geneticists.

Quantifiable outcome

• 4.8% incremental diagnostic yield improvement for rare diseases using OpenAI o3 Deep Research model
• +5 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability8 records

Feature6 records

Partnerships

15 partnerships are on record, tiered minor and core.

• Dr.Look AiminorOthers · 26 June 2026Dr.Look Ai, a children's technology brand and two-time international design award winner, donated its AI Learning Cameras to Boston Children's Hospital (and Seattle Children's) to address children's over-reliance on screens and provide age-appropriate learning tools for hospitalized children. The AI Learning Camera features AI object recognition within a closed, ad-free system supporting five languages.
• Nippon Shinyaku Co., Ltd.coreStrategic or Co-development Partner · 23 June 2026Nippon Shinyaku entered into a Sponsored Research Agreement with Boston Children's Hospital to co-develop innovative therapeutic drugs in neurology. The partnership builds on a strategic collaboration initiated in July 2025, combining Boston Children's research capabilities with Nippon Shinyaku's drug discovery expertise to accelerate new neurologic treatments for patients with unmet medical needs. The collaboration was facilitated by NS Pharma's Innovation Research Partnering team located in Cambridge, Massachusetts.
• OpenAIcoreTechnology or Integration · 18 June 2026Boston Children's Hospital's Manton Center for Orphan Disease Research collaborated with Harvard University and OpenAI to use the OpenAI o3 Deep Research reasoning model to reanalyze 376 previously unsolved rare disease cases, establishing 18 additional diagnoses. OpenAI has committed $50 million to support Boston Children's AI initiatives. More than one-third of hospital employees now use AI tools.
• Manton Center for Orphan Disease ResearchcoreStrategic or Co-development Partner · 18 June 2026Boston Children's Manton Center for Orphan Disease Research served as the primary research institution leading the OpenAI o3 Deep Research collaboration for rare disease diagnosis, collaborating with Harvard and OpenAI to reanalyze 376 previously unsolved pediatric cases.
• Cancer Grand Challenges NexTGen TeamminorStrategic or Co-development Partner · 8 April 2026Boston Children's Hospital is a US arm lead for the Cancer Grand Challenges NexTGen international clinical trial testing CAR T-cell immunotherapy in children with solid tumors. The global initiative is co-funded by Cancer Research UK, the National Cancer Institute, and The Mark Foundation for Cancer Research.
• ClaspminorOthers · 31 March 2026Clasp, a healthcare workforce infrastructure company offering student loan repayment tied to tenure, counts Boston Children's Hospital as a customer. Clasp has helped healthcare employers allocate more than $130 million across thousands of student loan repayment programs, with approximately 2.5x higher retention rates than traditional hiring models.
• MayeDay Family FoundationminorOthers · 29 March 2026The MayeDay Family Foundation, founded by Patriots quarterback Drake Maye and his wife Ann Michael, committed to a three-year partnership with Boston Children's Hospital to fund a full-time Child Life Therapist position for the oncology floor. The foundation's inaugural Celebrity Softball Classic raised funds for the hospital.
• Critical Path Institute - One to Millions InitiativeminorStrategic or Co-development Partner · 28 March 2026Boston Children's Hospital participates in the Critical Path Institute's global 'One to Millions' public-private partnership aimed at scalable development of advanced therapies for highly individualized diseases, working with n-Lorem Foundation, Mila's Miracle Foundation, and the N=1 Collaborative to accelerate regulatory approval through standardized protocols and data sharing.
• Parmenter FoundationminorOthers · 3 February 2026The Parmenter Foundation, which has provided over $4 million in funding since 2015, announced $400,000 in grants for 2026 including support for Boston Children's Hospital for end-of-life, grief, and bereavement programs in the MetroWest Massachusetts region.
• Zarminali PediatricsminorOthers · 21 January 2026Boston Children's Hospital participated as a co-investor in Zarminali Pediatrics' $110 million Series A funding round alongside Healthier Capital and General Catalyst. Zarminali provides in-person and virtual pediatric care across eight states.
• Digital Medicine Society (DiMe)minorStrategic or Co-development Partner · 9 January 2026Boston Children's Hospital is a founding partner in DiMe's 'Scaling Trusted, High-Impact AI Care Navigation' initiative alongside Google for Health, Mass General Brigham, Stanford Medicine, and over 15 other organizations. The initiative develops evidence-based standards and frameworks for responsible AI adoption in patient care navigation.
• Harvard Medical School MEDscience ProgramminorOthers · 1 December 2025Harvard Medical School's MEDscience program, in collaboration with Boston Children's Hospital and Moonshot, provides high school students with hands-on medical technology education through simulations using 3D printed anatomy, LEGO-compatible models, and robotic challenges.
• Broad Clinical LabscoreStrategic or Co-development Partner · 16 October 2025Broad Clinical Labs, in collaboration with Roche Sequencing Solutions and Boston Children's Hospital, achieved the Guinness World Record for fastest DNA sequencing, completing a full human genome in under 4 hours. This enables same-day genome analysis to inform urgent clinical decisions, especially in neonatal intensive care units.
• Dana-Farber Cancer InstitutecoreStrategic or Co-development Partner · 15 August 2025Three Boston-based institutions — Dana-Farber Cancer Institute, Boston Children's Hospital, and Broad Clinical Labs — launched BrightSeq, a collaborative initiative to improve pediatric cancer diagnostics through precision genomics. The initiative develops and implements novel clinical diagnostic assays for rare pediatric cancers, focusing on genomic analysis and liquid biopsies.
• Harvard UniversitycoreStrategic or Co-development Partner · 15 August 2025Harvard University researchers collaborated with Boston Children's Hospital's Manton Center and OpenAI on the o3 Deep Research rare disease study. Boston Children's is a Harvard-affiliated teaching hospital with integrated research programs.

Scale indicators10 records

Recent moves7 records

Expansion highlights6 records

Market position

Competitive moat6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/user/ChildrensHospital
• Facebookfacebook.com/BostonChildrensHospital
• LinkedInlinkedin.com/company/bostonchildrenshospital
• Instagraminstagram.com/bostonchildrens
• Pinterestpinterest.com/bostonchildrens
• Xx.com/bostonchildrens

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Subsidiaries7 records

Funding overview

Funding rounds9 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments7 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Boston Children's Hospital